Search

everythinglearnresearchcommunity

for

Search:↓

Consider NF1 in newborns with rare congenital anomalies.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Minoxidil improved hair growth in a child with a rare genetic disorder.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

A new microneedle treatment shows promise for better hair regrowth in androgenetic alopecia.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Measuring 24-OHase induction helps identify defects in vitamin D processing and predict treatment response.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

TCHHL1 is a protein important for hair growth, found in hair follicles.

A new compound shows promise as a topical treatment for hair loss.

DDR-II hair follicle cells don't respond to 1, 25-dihydroxyvitamin D3, aiding diagnosis.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

MK-386 lowers DHT in blood and skin but not in semen.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Male cells need DHT to respond to testosterone, while female cells do not.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Early diagnosis of Trichorhinophalangeal syndrome type 1 is crucial for treatment and was achieved through clinical examination and family history.

People with myotonic dystrophy type 1 tend to develop basal cell carcinoma at a younger age but not more frequently than others.

People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.

In India, most patients with type 1 autoimmune polyglandular failure show symptoms in a specific order, starting with parathyroid gland issues, then yeast infections, and finally adrenal gland failure.

A man with myotonic dystrophy type 1 had 28 skin cancers, suggesting a link between the disease and skin cancer, emphasizing the need for sun protection and regular skin checks.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

β-sitosterol and brassicasterol may help treat hair loss.